Prospective Grant of Exclusive License: Software for Predicting Molecular Properties and Pathogen Detection

摘要

This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive worldwide license to practice the invention embodied in E- 169-2000/0 "Drift Compensation Method for Fingerprint Spectra," U.S. Patent Application No. 09/975,530 filed October 10, 2001; E-297-2001/0 "Methods For Predicting Properties of Molecules," U.S. Patent Application No. 10/383,602 filed March 7, 2003; and E-017-2003/0 "Improved Pattern Recognition Of Whole Cell Mass Spectra Via Separation Of Specific Charge States," U.S. Patent Application No. 10/ 863,745 filed June 7, 2004; to Litmus, LLC an Arkansas corporation having its headquarters in Little Rock, Arkansas. The United States of America is the assignee of the patent rights of the above inventions. The contemplated exclusive license may be granted in the field of providing software solutions for pathogen detection and for predicting molecular properties.